Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations:A Randomized Controlled Trial

NCT07320001 is registered in ClinicalTrials.gov with Basharat Hussain as lead sponsor.

NCT NCT07320001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07320001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations:A Randomized Controlled Trial
Lead sponsor
Basharat Hussain
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 26, 2026
Completion date
September 26, 2026
Enrollment
92 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic abnormality